| Discovery is in our DNA
Jeffrey M. Gallagher, Chief Executive Officer of Virginia Bio, is responsible for leading the premier statewide trade group that promotes the considerable scientific and economic impact of the life sciences industry in the Commonwealth of Virginia
Jeff Gallagher assumed the position of Interim Executive Director with Virginia Bio on May 21, 2012, and was subsequently named CEO on September 24, 2012. For the previous 11 years he was VP & General Counsel for Lyotropic Therapeutics, a small Ashland specialty pharma company which used its proprietary formulation technology to create new drug products based on both new and already approved API for license, further development and commercialization by mid and large pharma. Previously he practiced corporate law in Richmond, including new technology company formation and international business. He was a co-founder and longtime Chair of the Richmond based nonprofit World Pediatric Project.
He holds an A.B. in Government from Harvard, a J.D. from the University of Wisconsin Law School, and an LL.M from the University of Virginia School of Law. He resides with his family in the Ginter Park area of Richmond.